Composition, form of production and packaging
? Tablets for resorption (orange) orange, round, biconvex, with a rough surface; uneven staining, the presence of air bubbles and a slight unevenness of the edges.
1 tab.
amylmethacresol 0.6 mg
2,4-dichlorobenzyl alcohol 1.2 mg
Excipients: sucrose 1618 mg, dextrose 830.4 mg, citric acid monohydrate 21 mg, orange oil 7.515 mg, anise seed oil 2.53 mg, mint leaf oil 1.32 mg, dye sunset yellow 0.30 mg.
4 things. - Strips aluminum (2) - packs cardboard.
4 things. - Strips aluminum (3) - packs cardboard.
4 things. - Strips aluminum (4) - packs cardboard.
8 pcs. - Al / PVC blisters (2) - cardboard packs.
8 pcs. - blisters Al / PVC (3) - packs cardboard.
? Reducing tablets (lemon) yellow, round, biconvex, with a rough surface; uneven staining, the presence of air bubbles and a slight unevenness of the edges.
1 tab.
amylmethacresol 0.6 mg
2,4-dichlorobenzyl alcohol 1.2 mg
Excipients: sucrose 1618 mg, dextrose 830.4 mg, citric acid monohydrate 21 mg, anise seed oil 2.53 mg, mint leaf oil 1.32 mg, lemon oil concentrate 7.7 mg, quinoline yellow color 0.175 mg.
4 things. - Strips aluminum (2) - packs cardboard.
4 things. - Strips aluminum (3) - packs cardboard.
4 things. - Strips aluminum (4) - packs cardboard.
8 pcs. - Al / PVC blisters (2) - cardboard packs.
8 pcs. - blisters Al / PVC (3) - packs cardboard.
? Tablets for resorption (honey-lemon) from brownish-yellow to brown, round, biconvex, with a rough surface; uneven staining, the presence of air bubbles and a slight unevenness of the edges.
1 tab.
amylmethacresol 0.6 mg
2,4-dichlorobenzyl alcohol 1.2 mg
Excipients: sucrose 1618 mg, dextrose 830.4 mg, mint leaves, oil 1.25 mg, lemon oil 1.25 mg, honey flavoring 7.5 mg, caramel dye 0.625 mg, dye sunset yellow 0.0375 mg.
4 things. - Strips aluminum (2) - packs cardboard.
4 things. - Strips aluminum (3) - packs cardboard.
4 things. - Strips aluminum (4) - packs cardboard.
8 pcs. - Al / PVC blisters (2) - cardboard packs.
8 pcs. - blisters Al / PVC (3) - packs cardboard.
? Tablets for resorption (black currant) violet, round, biconcave, with a rough surface; uneven staining, the presence of air bubbles and a slight unevenness of the edges.
1 tab.
amylmethacresol 0.6 mg
2,4-dichlorobenzyl alcohol 1.2 mg
Auxiliary substances: sucrose 1618 mg, dextrose 830.4 mg, citric acid monohydrate 15 mg, mint leaves, oil 1.25 mg, black currant flavor 6.25 mg, azorubin dye 0.0625 mg, brilliant blue dye 0.0275 mg.
4 things. - Strips aluminum (2) - packs cardboard.
4 things. - Strips aluminum (3) - packs cardboard.
4 things. - Strips aluminum (4) - packs cardboard.
8 pcs. - Al / PVC blisters (2) - cardboard packs.
8 pcs. - blisters Al / PVC (3) - packs cardboard.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2014.
PHARMACHOLOGIC EFFECT
The drug has an antiseptic effect, is active against gram-positive and gram-negative microorganisms in vitro, has antimycotic action.
INDICATIONS
- treatment of infectious and inflammatory diseases of the oral cavity and pharynx.
DOSING MODE
Adults and children over 6 years of age: rassasyvat 1 tab. every 2-3 hours. The maximum daily dose is 8 tablets.
SIDE EFFECT
Allergic reactions.
CONTRAINDICATIONS
- children's age till 6 years;
- Hypersensitivity to components.
PREGNANCY AND LACTATION
Pregnant and lactating women should consult a doctor before using the drug.
APPLICATION FOR CHILDREN
Contraindicated in children under 6 years. Possible use in children older than 6 years according to indications.
SPECIAL INSTRUCTIONS
Do not use the drug in the presence of increased individual sensitivity to any component that is part of the drug.
When prescribing the drug for patients with diabetes it is necessary to take into account the presence of sugar in the drug.
Impact on the ability to drive vehicles and manage mechanisms
The drug does not affect the ability to drive and maintain moving mechanical equipment.
OVERDOSE
Cases of drug overdose when used in recommended doses are not noted.
DRUG INTERACTION
Clinically significant interaction with drugs of other groups was not revealed.
TERMS OF RELEASE FROM PHARMACY
The drug is approved for use as a means of OTC.
TERMS AND CONDITIONS OF STORAGE
Store at a temperature not exceeding 30 В° C in a dry place inaccessible to children. Shelf life - 4 years. Do not use after the expiration date printed on the package.
